University of Miami Sylvester Comprehensive Cancer Center
Avatar

COVID-19 Pandemic: Preparation Protocols, Telemedicine, and Modifying Treatment for Cancer Patients

By University of Miami Sylvester Comprehensive Cancer Center FEATURING Gilberto Lopes
April 1, 2020
10 Comments
Login to view comments. Click here to Login

Featured Video

06:28
Lilly Oncology

A Case Study of HR+, HER2- MBC With Rapid Progression

Feat. M. Dietrich

Featured Video

12:13
Lilly Oncology

Efficacy of a Treatment in Combination With Endocrine-Based Therapy

Feat. M. Dietrich

Related Content

AUTOPLAY
Nebraska Oncology Society

Nebraska Oncology Society Evening Speaker Series - Virtual Hematology Upda…

Wed, May 5, 2021
21:42
UAB Hematology Review 2021

Hematologic Manifestations of COVID-19: Thrombosis Mechanisms and Risk, CO…

Feat. R. Gangaraju
10:25
Houston Methodist DeBakey Heart and Vascular Center

COVID-19 & Cytokine Storm: What Kind of Inflammatory Markers Are Released …

Feat. J. Chang
15:32
Penn Medicine Abramson Cancer Center

COVID-19 Vaccination Guidelines for Our Cancer Patients: What Are the Elig…

Feat. L. Schuchter
12:10
Penn Medicine Abramson Cancer Center

2021 Updates in Medical Oncology for Lung Cancer: Targeted Therapy, Tumor …

Feat. C. Aggarwal
16:58
Cleveland Clinic's 2021 Management of Checkpoint Inhibitor-Related Toxicity

Lessons Learned From irAE Management During COVID-19: Cytokine Storm, Impl…

Feat. L. Calabrese
15:18
Memorial Sloan Kettering Cancer Center

MSKCC Updates on Telemedicine/Cohort Monitoring & COVID-19 Testing for Che…

Feat. D. Reidy-Lagunes
13:34
UAB Hematology Review 2021

2021 Update on CLL: Frontline Acalabrutinib or Ven +/- Obi, Ibrutinib, Pts…

Feat. M. Narkhede
33:00
Total Health Conferencing

Will COVID-19 Leave Its Mark on Cancer Care?

Feat. G. Lopes
15:40
ASH Review VIRTUAL 2020: Current Updates in Hematologic Diseases

COVID-19 & Hematologic Malignancies: What Is the Mortality Estimate Per Ma…

Feat. J. Leal
17:35
ASH Review VIRTUAL 2020: Current Updates in Hematologic Diseases

COVID-19 Coagulopathy: What Is Virchow’s Triad? What Are the VTE Rates in …

Feat. P. Harris
13:17
Penn Medicine Abramson Cancer Center

Penn Updates on RT in Lung Cancer During COVID-19: SBRT vs. Surgery, Antim…

Feat. A. Berman
12:50
Moffitt Cancer Center

Melanoma Drug Therapy During COVID-19: When to Wait or Go Forward With the…

Feat. Z. Eroglu, V. Sondak
15:18
Penn Medicine Abramson Cancer Center

Penn Medicine Melanoma Management During COVID-19: What Are the Main Conce…

Feat. E. Chu, R. Bronfenbrener, C. J. Miller
10:01
Moffitt Cancer Center

COVID-19 in Lung Cancer Patients: Does Chemotherapy Increase the Severity …

Feat. M. Shafique
18:31
ASH Review VIRTUAL 2020: Current Updates in Hematologic Diseases

COVID-19 Therapeutics: Remdesivir/Bamlanivimab/Casirivimab+Imdevimab - Wha…

Feat. K. Konrardy
68:24
AstraZeneca Oncology

Continuing Lung Cancer Diagnosis, Workup, & Care Across the Spectrum of th…

Feat. G. Cumbo-Nacheli, J. Gorden, B. Stiles
11:47
Fox Chase Cancer Center's Genitourinary Malignancies in the Time of COVID-19

Fox Chase Experience on COVID-19 & Cancer: Disease Biology, Risks of Syste…

Feat. A. Kutikov
16:49
MD Anderson's The Art and Science of Managing the New Melanoma Landscape 2020

COVID-19 & Melanoma: Does the Mortality Rate Increase in Cancer Patients? …

Feat. J. McQuade
16:47
Fox Chase Cancer Center's Genitourinary Malignancies in the Time of COVID-19

Fox Chase COVID-19 Updates on Surgery for Bladder, Kidney & Prostate Cance…

Feat. R. Viterbo
09:21
Moffitt Cancer Center

Melanoma Therapy During COVID-19: How to Deal With Coronavirus Positive Pa…

Feat. E. Wuthrick, A. Richards, V. Sondak